These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2695321)

  • 1. Plasma glucagon response to intravenous alanine in obese and non-obese subjects.
    Asano T; Ninomiya H; Kan K; Yamamoto T; Okumura M
    Endocrinol Jpn; 1989 Oct; 36(5):767-73. PubMed ID: 2695321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic glucagon response to glucose in obesity with normal and impaired carbohydrate tolerance.
    Ratzmann KP; Schulz B; Witt S; Ziegler M
    Int J Obes; 1981; 5(2):163-9. PubMed ID: 7014481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma glucose, insulin (IRI), glucagon (IRG) and free fatty acids (FFA) following alanine loading in hyperthyroid patients.
    Ida H; Yamamoto T; Ninomiya H; Sasaki H; Asano T; Okumura M
    Endocrinol Jpn; 1987 Dec; 34(6):937-45. PubMed ID: 3330025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
    Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Torella R; Franchimont P; Lefebvre PJ; D'Onofrio F
    Metabolism; 1992 Feb; 41(2):184-90. PubMed ID: 1736041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of obesity on basal glucagon levels in non-diabetic and diabetic Nauruans.
    Alford FP; Zimmet P; Chisholm DJ; Whitehouse S
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):721-5. PubMed ID: 6360432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas.
    Gerich JE; Charles MA; Grodsky GM
    J Clin Invest; 1974 Oct; 54(4):833-41. PubMed ID: 4430717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism underlying the influence of alanine infusion on glucose dynamics in the dog.
    Saccà L; Trimarco B; Perez G; Rengo F
    Diabetes; 1977 Apr; 26(4):262-70. PubMed ID: 300341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
    Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
    Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas.
    Ohneda A; Ohneda M
    Tohoku J Exp Med; 1988 Jun; 155(2):197-204. PubMed ID: 3062845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
    Costin G; Kogut MD; Hyman C; Ortega JA
    Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated pancreatic glucagon in obesity.
    Starke AA; Erhardt G; Berger M; Zimmermann H
    Diabetes; 1984 Mar; 33(3):277-80. PubMed ID: 6365661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic leucine-sensitive hypoglycemia syndrome: insulin and glucagon responses and effects of diazoxide.
    Roe TF; Kogut MD
    Pediatr Res; 1982 Jan; 16(1):1-4. PubMed ID: 7041064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenergic modulation of pancreatic hormone secretion in utero: studies in fetal sheep.
    Sperling MA; Christensen RA; Ganguli S; Anand R
    Pediatr Res; 1980 Mar; 14(3):203-8. PubMed ID: 6992082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.